News | October 21, 2011

OCT Intravascular Imaging Technology Platform Now Available in India

October 21, 2011 – St. Jude Medical announced the launch of the C7-XR optical coherence tomography (OCT) intravascular imaging system with the C7 Dragonfly Imaging Catheter in India. OCT is a next-generation coronary imaging technology platform that aids physicians in the diagnosis and treatment of cardiovascular disease, and is used by interventional cardiologists to assist with stent selection and provide post-stenting information.

OCT technology utilizes near-infrared light to create images that go beyond older coronary imaging technologies – such as fluoroscopy and intravascular ultrasound (IVUS) – offering cardiologists an assessment method with enhanced clarity for their patients with coronary artery disease. With the technology, physicians can visualize and measure important vessel characteristics that are otherwise not visible or difficult to assess with the older imaging technology. Additionally, images are created with 10 times the resolution of intravascular ultrasound technology.

“OCT presents a new landmark in coronary imaging whereby we would be able to see micro structures in coronary arteries, which provides diagnostic information that will help me to perform optimal angioplasty,” said Ashok Seth, M.D., chairman of the Fortis Group of Hospitals. “OCT technology can help me to see early and soft blockages which occur in younger patients and have high risk of causing heart attacks. The images make it almost feel as if the inside of the coronary artery was being seen with the naked eye.”

The imaging capabilities assist physicians in stent selection by providing them with measurements of lesion length and vessel size and structure. Additionally, the OCT technology provides physicians with post-stenting positioning, potentially minimizing the need for repeat revascularization. At follow-up, the technology provides detailed information regarding the inner lining of the vessel and whether there is a recurrence of blood vessel narrowing, also known as stenosis.

According to Seth, in addition to helping determine stent size, OCT can also assist with stent placement, which he believes could help to improve short term and long-term safety and improve patient results.

The C7-XR System with the C7 Dragonfly Imaging Catheter was launched in Europe in May 2009. St. Jude Medical offers the only commercially available intracoronary OCT imaging device in the world. The C7-XR Coronary Imaging System is commercially available in the United States, Europe and Australia.

For more information: www.sjm.com

 

Related Content

Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
Videos | Cath Lab | September 14, 2018
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS.
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Overlay Init